---
title: "Bio-Techne retention bonuses approved for Kim Kelderman, Jim Hippel"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290948213.md"
description: "Bio-Techne approved cash retention bonuses for five named executive officers, including Kim Kelderman and Jim Hippel, in connection with a contemplated merger. The bonuses, ranging from approximately $910,000 to $2.1 million, are designed to encourage retention until the merger's effective date of June 23, 2026. Payments are contingent upon continued employment or qualifying termination and the execution of a release."
datetime: "2026-06-26T10:03:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290948213.md)
  - [en](https://longbridge.com/en/news/290948213.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290948213.md)
---

# Bio-Techne retention bonuses approved for Kim Kelderman, Jim Hippel

**Bio-Techne approved cash retention bonuses for named executive officers in connection with the contemplated merger.**

**Individual**

Kim Kelderman

Jim Hippel

William Geist

Shane Bohnen

Steve Crouse

**Role**

Named executive officer

Named executive officer

Named executive officer

Named executive officer

Named executive officer

**Type of Change**

Retention bonus approved

Retention bonus approved

Retention bonus approved

Retention bonus approved

Retention bonus approved

**Effective Date**

June 23, 2026 (effective upon execution of Merger Agreement)

June 23, 2026 (effective upon execution of Merger Agreement)

June 23, 2026 (effective upon execution of Merger Agreement)

June 23, 2026 (effective upon execution of Merger Agreement)

June 23, 2026 (effective upon execution of Merger Agreement)

**Reason**

To encourage retention and continued performance until the Effective Time

To encourage retention and continued performance until the Effective Time

To encourage retention and continued performance until the Effective Time

To encourage retention and continued performance until the Effective Time

To encourage retention and continued performance until the Effective Time

**Replacement Info**

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

**Background Details**

Retention agreement provides $2,120,976 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution

Retention agreement provides $1,541,510 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution

Retention agreement provides $1,161,014 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution

Retention agreement provides $971,097 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution

Retention agreement provides $910,263 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution

**Board/Committee Role Changes**

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Original SEC Filing: BIO-TECHNE Corp \[ TECH \] - 8-K - Jun. 25, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)

## Related News & Research

- [Bio-Techne to Be Acquired by Merck for $73 Per Share in All-Cash Merger](https://longbridge.com/en/news/290948205.md)
- [Bio-Techne (TECH) Stock Could Be 10.4% Undervalued After Refeyn Collaboration](https://longbridge.com/en/news/290154834.md)
- [The executive behind M&M's says this is marketing's most overlooked skill](https://longbridge.com/en/news/290541106.md)
- [OPS Italia revises 2026 corporate events calendar](https://longbridge.com/en/news/290718405.md)
- [McCormick Q2 2026 Earnings Preview](https://longbridge.com/en/news/290743751.md)